GLOBUS MEDICAL, INC. Treasury Stock Acquired, Average Cost Per Share
GLOBUS MEDICAL, INC. (GMED) reported Treasury Stock Acquired, Average Cost Per Share of $60.12 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:TreasuryStockAcquiredAverageCostPerShare · last filed 2025-11-06
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for the quarter ending 2025-09-30 was $60.12.
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for the quarter ending 2025-06-30 was $60.81, a 22.43% increase year-over-year.
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for the quarter ending 2025-03-31 was $77.91, a 49.31% increase year-over-year.
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for the quarter ending 2024-06-30 was $49.67.
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for fiscal 2024 was $52.14.
- GLOBUS MEDICAL, INC. treasury stock acquired, average cost per share for fiscal 2020 was $38.91.
| Period end | Treasury Stock Acquired, Average Cost Per Share 3 month | Treasury Stock Acquired, Average Cost Per Share 6 month | Treasury Stock Acquired, Average Cost Per Share 9 month | Treasury Stock Acquired, Average Cost Per Share 12 month | Treasury Stock Acquired, Average Cost Per Share 15 month | Treasury Stock Acquired, Average Cost Per Share 18 month | Treasury Stock Acquired, Average Cost Per Share 21 month | Treasury Stock Acquired, Average Cost Per Share 24 month | Treasury Stock Acquired, Average Cost Per Share 27 month | Treasury Stock Acquired, Average Cost Per Share 30 month | Treasury Stock Acquired, Average Cost Per Share 33 month | Treasury Stock Acquired, Average Cost Per Share 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $60.12 10-Q · filed 2025-11-06 | $72.55 10-Q · filed 2025-11-06 | ||||||||||
| 2025-06-30 | $60.81 10-Q · filed 2025-08-07 | $75.45 10-Q · filed 2025-08-07 | ||||||||||
| 2025-03-31 | $77.91 10-Q · filed 2025-05-08 | |||||||||||
| 2024-12-31 | $52.14 10-K · filed 2025-02-20 | |||||||||||
| 2024-09-30 | $52.14 10-Q · filed 2024-11-05 | |||||||||||
| 2024-06-30 | $49.67 10-Q · filed 2024-08-06 | $52.14 10-Q · filed 2024-08-06 | ||||||||||
| 2024-03-31 | $52.18 10-Q · filed 2024-05-07 | |||||||||||
| 2022-12-31 | $49.42 10-K · filed 2023-02-21 | |||||||||||
| 2022-09-30 | $49.42 10-Q · filed 2022-11-08 | |||||||||||
| 2022-06-30 | $61.45 10-K · filed 2023-02-21 | $49.42 10-Q · filed 2022-08-04 | ||||||||||
| 2022-03-31 | $38.91 10-Q · filed 2022-05-10 | |||||||||||
| 2021-12-31 | $38.91 10-K · filed 2022-02-17 | |||||||||||
| 2021-09-30 | $38.91 10-Q · filed 2021-11-04 | |||||||||||
| 2021-06-30 | $38.91 10-Q · filed 2021-08-04 | |||||||||||
| 2021-03-31 | $38.91 10-Q · filed 2021-05-04 | |||||||||||
| 2020-12-31 | $38.91 10-K · filed 2021-02-17 | |||||||||||
| 2020-09-30 | $38.91 10-Q · filed 2020-10-28 | |||||||||||
| 2020-06-30 | $39.95 10-K · filed 2023-02-21 | $38.91 10-Q · filed 2020-08-05 | ||||||||||
| 2020-03-31 | $38.49 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |